Skip to content
The Policy VaultThe Policy Vault

ribavirin inhalation solutionMedica

Respiratory Syncytial Virus (RSV), Treatment

Initial criteria

  • Patient is < 2 years of age
  • Patient is hospitalized
  • Medication is prescribed by or in consultation with a critical care or pulmonary specialist

Approval duration

1 month